REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbon Atoms > Polycyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos > Tetracyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos > Two Of The Cyclos Share At Least Three Ring Members (i.e., Bridged) (e.g., Morphinans, Etc.) Two Of The Cyclos Share At Least Three Ring Members (i.e., Bridged) (e.g., Morphinans, Etc.)Two Of The Cyclos Share At Least Three Ring Members (i.e., Bridged) (e.g., Morphinans, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.05/25/06 - 20060111384 - 4-hydroxybenzomorphans 4-Hydroxybenzomorphans containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. ... 02/23/06 - 20060040970 - Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group (wherein R1 is methyl, cyclopropylmethyl or the like; R2 and R3 are hydroxy, methoxy, acetoxy or the like; both Y and Z are valence bonds, —C(═O)— or the like; X is C2-C5 carbon chain (one of the carbon atoms may be substituted by oxygen, sulfur or nitrogen) constituting a part ... 07/21/05 - 20050159440 - N-substituted derivatives of morphinan and uses thereof The invention is based in part on the discovery that nonselective ε agonists that possess μ receptor-mediated effects in addition to their ε agonist effects can decrease cocaine self-administration more effectively and with fewer undesirable side effects than can highly selective ε agonists. The invention includes a number of new ... ### FreshPatents.com Support |